# 2026-08511: Medicare Meeting on 2027 Lab Test Payment Codes

2026-08511, Medicare Program: Public Meeting Regarding New and Reconsidered Clinical Diagnostic Laboratory Test Codes for the Clinical Laboratory Fee Schedule for Calendar Year 2027, is a Federal Register notice from Health and Human Services Department, Centers for Medicare & Medicaid Services published 2026-05-01, effective 2026-06-10; PRIA reads it as touching household money (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2026-08511
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-08511
- Title: Medicare Program: Public Meeting Regarding New and Reconsidered Clinical Diagnostic Laboratory Test Codes for the Clinical Laboratory Fee Schedule for Calendar Year 2027
- Type: Notice
- Agencies: Health and Human Services Department; Centers for Medicare & Medicaid Services
- Citation: 91 FR 23421
- Published: 2026-05-01
- Effective: 2026-06-10
- Comments close: not stated
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

Medicare Meeting on 2027 Lab Test Payment Codes

## Summary

Medicare is hosting a public meeting on June 10, 2026, to talk about new and updated lab test codes that affect how much Medicare pays for these tests in 2027. Labs, doctors, and anyone interested can share their thoughts and data before May 29, 2026. This meeting helps decide fair payments and could impact lab test costs and Medicare budgets next year.

## Abstract

This notice announces a public meeting to receive comments and recommendations (including data on which recommendations are based) on the appropriate basis for establishing payment amounts for new or substantially revised Healthcare Common Procedure Coding System codes being considered for Medicare payment under the Clinical Laboratory Fee Schedule for calendar year 2027. This meeting also provides a forum for those who submitted certain reconsideration requests regarding final determinations made last year on new test codes and for the public to provide comment on the requests.

## Effects PRIA read

- How Medicare Will Price New Lab Tests: mixed, medium. Medicare will set payment amounts for new or substantially revised clinical diagnostic laboratory test (CDLT) HCPCS codes for calendar year 2027 using one of two methods: "crosswalking" (pricing the new test comparable to existing tests) or "gapfilling" (if no comparable test exists). These methods…
- Gapfilling: Local First-Year Payments, Median Year Two: mixed, medium. When gapfilling is used, each Medicare Administrative Contractor (MAC) sets a Part B geographic-area payment amount for the new test in the first year using sources like charges, test costs, and other payers. In the second year, Medicare pays the test code at the median of those MAC-specific amount…
- Deadlines and Opportunity To Comment: benefit, low. CMS will hold a hybrid public meeting on June 10, 2026, and requires presenters and written comments to be submitted by May 29, 2026 at 5:00 p.m. E.D.T. CMS plans to publish proposed determinations by early September 2026 (with comments due in October 2026) and to post final determinations in Novem…
- Limits on Reconsideration for Reconsidered Codes: cost, medium. The notice states that final determinations for reconsidered codes are not subject to further reconsideration. For final determinations on new test codes, the public may request reconsideration of the basis and amount of payment under Sec. 414.509.

## Related documents

- [2026-22812](https://policyrisk.com/federal-register/2026-22812): Medicare and Medicaid Programs; Cutting Administrative Requirements for Excellence in Patient Care, 2026-11-10
- [2026-22750](https://policyrisk.com/federal-register/2026-22750): Calendar Year 2027 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the E…, 2026-11-09
- [2026-22792](https://policyrisk.com/federal-register/2026-22792): Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program, 2026-11-09
- [2026-22743](https://policyrisk.com/federal-register/2026-22743): Medicare and Medicaid Programs; CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage…, 2026-11-09
- [2026-22739](https://policyrisk.com/federal-register/2026-22739): Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; and Quality Reporting Programs; i…, 2026-11-06
- [2026-22381](https://policyrisk.com/federal-register/2026-22381): Medicare and Medicaid Programs; Organ Procurement Organizations Conditions for Coverage: Revisions to the Conditions for Coverage, 2026-11-03

## Sources
- [2026-08511 on federalregister.gov](https://www.federalregister.gov/documents/2026/05/01/2026-08511/medicare-program-public-meeting-regarding-new-and-reconsidered-clinical-diagnostic-laboratory-test)
- [2026-08511 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-05-01/pdf/2026-08511.pdf)

## Related
- [Previous: 2026-08510, Steel Grating From China; Institution of Five-Year Reviews](https://policyrisk.com/federal-register/2026-08510)
- [Next: 2026-08512, Medicare Program: Rechartering, Membership, and Meeting Announcement for the Me…](https://policyrisk.com/federal-register/2026-08512)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-08511 (as of 2026-06-08).
